## Abstract Levodopa (L‐dopa) and subthalamic nucleus (STN) stimulation treatments have been associated with both improvement and exacerbation of dysarthria in Parkinson's disease (PD). We report four cases illustrating variant responses of dysarthria to dopaminergic and STN stimulation therapies.
Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients
✍ Scribed by Dr. Patricia Limousin; Pierre Pollak; Dominique Hoffmann; Abdelhamid Benazzouz; Jean Edmond Perret; Alim-Louis Benabid
- Book ID
- 102506517
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 444 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0885-3185
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Chronic electrical subthalamic nucleus (STN) stimulation is under investigation for alleviating parkinsonian symptoms. STN alterations may carry the risk of provoking abnormal involuntary movements (AIMs). We took advantage of the reversibility of the stimulation technique to assess the possibility of inducing AIMs, using different electrical variables with or without concomitant levodopa intake. Above a given threshold voltage, stimulation could induce contralateral distal mobile AIMs or hemiballism in the off‐drug condition in two patients. AIMs occurred after a latency that varied from a few minutes up to several hours after switching on the stinulator. Hemiballism immediately disappeared upon switching off the stimulator. In these patients, levodopa had never provoked that type of AIMs before surgery. Levodopa‐induced AIMs were not modified by electrical stimulation, but off‐phase dystonia disappeared in one patient. Stimulation of the STN induced AIMs that resembled both those observed following spontaneous lesions of the STN and levodopa‐induced diphasic AIMs in parkinsonian patients. As electrical stimulation provoked AIMs and antiparkinsonian benefit occurred with different electical variables and different timing, the mechanisms responsible for these two effects could be distinct.
📜 SIMILAR VOLUMES
## Abstract Subthalamic nucleus (STN) stimulation improves motor disability and quality of life in patients with advanced Parkinson's disease (PD). Short‐term mortality is low, but little is known about long‐term mortality. We assessed mortality and causes of death in 171 consecutive PD patients tr
## Abstract Deep brain stimulation of the subthalamic nucleus (STN–DBS) is an established therapy for Parkinson's disease (PD). A manic episode with psychotic symptoms induced by STN–DBS occurred in a previously psychiatrically healthy patient, focusing on the role of STN–DBS in influencing not onl